Objective-The G-protein-coupled receptor kinase interacting protein-1 (GIT1) is a scaffold protein that is important for phospholipase Cγ and extracellular signal-regulated kinase 1/2 signaling induced by angiotensin II and epidermal growth factor. Because GIT1 regulates signaling by several vascular smooth muscle cell (VSMC) growth factors, we hypothesized that intima formation would be inhibited by GIT1 depletion. Approach and Results-Complete carotid ligation was performed on GIT1 wild-type and knockout (KO) mice. We compared changes between GIT1 wild-type and KO mice in carotid vascular remodeling, VSMC proliferation, and apoptosis in vivo and in vitro. Our data demonstrated that GIT1 deficiency significantly decreased intima formation after carotid ligation as a result of both reduced VSMC proliferation and enhanced apoptosis. To confirm the effects of GIT1 in vitro, we performed proliferation and apoptosis assays in VSMC. In mouse aortic smooth muscle cells (MASM), we found that the growth rate and [3H]-thymidine incorporation of the GIT1 KO MASM were significantly decreased compared with the wild-type MASM. Cyclin D1, which is a key cell cycle regulator, was significantly decreased in GIT1 KO cells. Serum deprivation of GIT1 KO MASM increased apoptosis 3-fold compared with wild-type MASM. Treatment of rat aortic smooth muscle cells with GIT1 small interfering RNA impaired cell migration. Both phospholipase Cγ and extracellular signal-regulated kinase 1/2 signaling were required for GIT1-dependent VSMC proliferation and migration, whereas only phospholipase Cγ was involved in GIT1-mediated VSMC apoptosis. Key Words: extracellular signal-regulated kinase-1/2 ◼ G-protein-coupled receptor kinase interacting protein-1 ◼ intima formation ◼ phospholipase Cγ ◼ vascular smooth muscle cell apoptosis ◼ vascular smooth muscle cell proliferation
T he proliferation and migration of vascular smooth muscle cells (VSMCs) contributes to the development of atherosclerosis and restenosis after angioplasty. 1, 2 Several growth factors that activate G-protein-coupled receptors (GPCR, such as endothelin-1 and angiotensin II [AngII] ) and tyrosine kinase receptors (such as epidermal growth factor [EGF] and platelet-derived growth factor [PDGF]) trigger and control these processes. [2] [3] [4] We and others previously shown a number of shared signal events downstream of these receptors that require tyrosine phosphorylation 5, 6 mediated by cellular sarcoma. Among these signals, we found that a key molecule was the GPCR-kinase interacting protein-1 (GIT1). GIT1 is a multidomain scaffold protein 7 that associates with G protein receptor kinase-1 to regulate GPCR endocytosis 8 ;
GIT1 interacts with mitogen-activated protein kinase-1 to activate extracellular signal-regulated kinase (ERK) 1/2 9 ; it can also bind to phospholipase Cγ (PLCγ), which is required for PLCγ phosphorylation. 10 In addition, our laboratory showed that GIT1 is required for ERK1/2 translocation and activation in focal adhesions, which are important for cell spreading and migration. 9, 11 Based on these data, we propose that GIT1 is essential for VSMC proliferation, apoptosis, and migration through PLCγ and ERK1/2 pathway induced by GPCR and tyrosine kinase receptor, which subsequently affects vascular remodeling.
Results

Intima Formation Was Decreased in GIT1 Knockout Mice
To determine the physiological role of GIT1 in vascular remodeling, we performed complete carotid artery ligation on GIT1 wild-type (WT) and knockout (KO) mice (n=8 in each group). At 3 months of age, there were no significant differences in the endothelium, media, and adventitia in GIT1 WT and KO mice. Four weeks after carotid artery ligation, WT mice exhibited a substantial increase in the intima ( Figure 1A , 1B, and 1E; 6.37±1.3×10 4 μm 2 ), whereas GIT1 KO mice had significantly less intima ( Figure 1C , 1D, and 1E; 3.05±0.72×10 4 μm 2 ; P<0.05) and a smaller intima/media ratio ( Figure 1F ; 0.86±0.12 versus 0.45±0.06; P<0.05). However, there was no significant difference in media or adventitia area between the 2 genotypes. In addition, we did not observe any differences between sham groups.
GIT1 Expression Was Enhanced After Complete Ligation
To determine the role of GIT1 in vascular remodeling, we measured the expression of GIT1 in carotid arteries after ligation or sham surgery in GIT1 WT and KO mice. GIT1 was expressed in both VSMC and endothelial cells in GIT1 WT carotid artery ( Figure 2A ). After ligation, GIT1 expression increased in intima of WT mice ( Figure 2B ). Western blot data demonstrated that GIT1 expression increased by 3.01-fold in intima of WT mice compared with the sham group ( Figure 2E and 2F). However, there was no GIT1 expression in GIT1 KO mice ( Figure 2C-2E ). To confirm our finding in vitro, GIT1 expression was detected in rat aortic smooth muscle cells (RASM) treated with various growth factors, including AngII, PDGF, EGF, and fetal bovine serum (FBS). We found that treatment with AngII, PDGF, or FBS for 8 hours significantly increased GIT1 mRNA expression, as measured by standard end-point PCR ( Figure I in the online-only Data Supplement; 2.87-, 2.83-, and 2.73-fold, respectively). Consistently, GIT1 protein expression significantly increased after 24-hour stimulation with AngII, FBS, and PDGF ( Figure 2G and 2H) . However, administration of EGF had no effect on GIT1 expression (data not shown).
GIT1 Was Required for VSMC Proliferation
To determine the role of GIT1 in VSMC proliferation in vivo, staining for proliferating cell nuclear antigen (PCNA), a cell proliferation maker, was performed on paraffin sections of carotid arteries (14 days after ligation). PCNA-positive cells in the GIT1 KO mice were significantly reduced compared with the GIT1 WT mice (Figure 3A-3C ; WT 10.01±0.67% versus KO 1.24±0.72%), which suggests that GIT1 is critical for cell proliferation. To confirm a difference in rates of proliferation, MASM were isolated from GIT1 WT and KO mice. MASM proliferation was measured by cell number counting and [3H]-thymidine incorporation. In response to 5% serum, the growth rate of KO cells was dramatically decreased compared with WT cells ( Figure 3D Figure 3E ). We published previously that GIT1 is critical for PLCγ and ERK1/2 activation. 9, 10 We presume that GIT1-mediated VSMC proliferation is through PLCγ-ERK1/2 pathway. Thus, we determined the effects of PD98059 (ERK1/2 inhibitor) and U73122 (PLCγ inhibitor) on VSMC proliferation. The growth curve in Figure 3F showed that inhibition of either PLCγ or ERK1/2 significantly reduced the RASM growth induced by . Representative cross sections of carotid arteries on day 28 (hematoxylin and eosin staining). White line indicates intima width. Bar is 100 μm. E and F, Quantification of intima, media, adventitial volume, and intima/media ratio. There is a significant decrease in intima volume and intima/media ratio in GIT1 KO mice. *P<0.05 vs GIT1 wild-type (WT) mice; n=8.
FBS, which suggested that GIT1-PLCγ-ERK1/2 pathway is important for VSMC proliferation. In addition, U73122 had stronger inhibitory effect than PD98059, which implied other downstream targets involved in GIT1-PLCγ pathway beyond ERK1/2.
GIT1 Was Critical for Cell Cycle Progression
In mammalian cells, cyclin D1 regulates the G 1 to S cell cycle transition. 12 To show further the role of GIT1 in VSMC growth, we measured cyclin D1 expression induced by serum in GIT1 WT and KO MASM. Serum stimulation for 9 hours increased cyclin D1 expression by 2-fold in GIT1 WT MASM, whereas in GIT1 KO MASM, both baseline and FBS-induced cyclinD1 expression decreased, which is consistent with the finding that GIT1 KO MASM showed significantly decreased cell proliferation both at basal condition and after FBS treatment ( Figures 3E, 4A , and 4B). Inhibition of PLCγ and ERK1/2 showed similar effects to GIT1 deletion ( Figure 4C and 4D). We next evaluated the stage of cell cycle most regulated by GIT1 in MASM. As expected, GIT1 deletion dramatically decreased the amount of cells in S phase, with a corresponding increase in G 0 -G 1 ( Figure 4E ).
GIT1 Reduced VSMC Apoptosis
It has been shown that VSMC apoptosis plays a key role in vascular remodeling. 13 To elucidate the role of GIT1 in VSMC apoptosis, we performed terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays on carotid arteries 1 and 14 days after ligation. We detected apoptotic cells at both the early time point (1 day) and later time point (14 days) after ligation. We did not observe any difference in apoptotic cells at the early time point (data not shown), but at the later time point, the number of apoptotic cells in the GIT1 KO carotid was significantly increased compared with GIT1 WT (4.3±0.61-fold; P<0.05; Figure 5A -5C). To confirm the role of GIT1 in VSMC apoptosis, we studied the effect of serum starvation on MASM isolated from GIT1 WT and KO aortas. Serum starvation significantly increased apoptosis in KO compared with WT cells (23.1±2.1% versus 8.56±2.67%; P<0.05; Figure  5D -5F). These data show that GIT1 is required for VSMC survival. Furthermore, the effects of PLCγ and ERK1/2 on VSMC apoptosis were assayed. Interestingly, we found that inhibition of PLCγ increased RASM apoptosis by 8.63-fold ( Figure 5G-5I ), whereas inhibition of ERK1/2 had no effect on RASM apoptosis (data not shown). These data suggested that GIT1-PLCγ pathway is crucial for VSMC survival.
GIT1 Was Critical for VSMC Migration
VSMC migration is critical for vascular remodeling.
14 GIT1 has been shown to play an important role in migration of various cell types, including endothelial cell, neuron, fibroblast, and A7R5 cell. [15] [16] [17] However, the role of GIT1 in primary cultured VSMC migration is still unknown. Thus, wound scratch assay was performed on RASM treated with control small interfering RNA or GIT1 small interfering RNA ( Figure 6A-6E) . Consistent with previous findings, GIT1-depleted cells demonstrated impaired migration stimulated by PDGF, although basal migration did not appear to differ at this level of GIT1 depletion. 11, 15, 17 Moreover, inhibition of PLCγ and ERK1/2 showed similar results as GIT1-depleted cells ( Figure 6F-6J ). All these data suggest an important role of GIT1-PLCγ and ERK1/2 pathway in VSMC migration.
GIT1 Was Required for ERK1/2 Activation After Carotid Ligation
Both GPCR and tyrosine kinase receptor signaling are essential for vascular remodeling. We have published previously that GIT1 is required for PLCγ and ERK1/2 activation induced by AngII and EGF. 9, 10 To explore the role of GIT1 in PLCγ and ERK1/2 activation in vivo during vascular remodeling, we measured PLCγ and ERK1/2 phosphorylation in carotid (mean±SE; n=3) . E, MASM from GIT1 WT and KO mice were growth-arrested by serum starvation for 24 hours and treated with 10% serum for 24 hours. Cells were then collected and subjected to flow cytometry (mean±SE). *P<0.05 vs WT; n=7.
arteries after 7 and 14 days ligation by immunohistochemistry and Western blot. Because of the limitation of the phospho-PLCγ antibody, we could not detect the expression of phospho-PLCγ at any time point (data not shown). There was minimal ERK1/2 activation at 14 days (data not shown). However, ERK1/2 activation was dramatically increased in VSMC in the GIT1 WT carotid at 7 days, whereas there was no change in the GIT1 KO carotid and sham groups ( Figure IIA -IID in the online-only Data Supplement). Western blot analysis showed that there was 2.47±0.27-fold increase in ERK1/2 activation in GIT1 WT ligated carotid compared with WT sham ( Figure IIE and IIF in the online-only Data Supplement). In contrast, there was no obvious increase in ERK1/2 activation in KO carotid.
Discussion
The major finding of this study is that GIT1 is an important regulator of vascular remodeling. Specifically, we found that GIT1 depletion inhibited intima formation after carotid ligation by 50%. In vivo and in vitro analysis showed a key role for GIT1 in VSMC proliferation, migration, and apoptosis during vascular remodeling ( Figure III in the online-only Data Supplement). Furthermore, GIT1 is required for VSMC proliferation through PLCγ and ERK1/2 by regulating the expression of cell cycle-related proteins, such as cyclin D1. GIT1 is also essential for cell survival by regulating VSMC apoptosis through PLCγ and cell migration through PLCγ and ERK1/2.
VSMC proliferation and migration are key components in vascular remodeling.
1,2 The present study shows that GIT1 expression is highly regulated by AngII and PDGF in vitro, and during vascular remodeling in vivo. The role of GIT1 in mediating VSMC proliferation was demonstrated by several assays, including in vitro cell count, [3H]-thymidine incorporation, and cell cycle analysis. Several groups, including our laboratory, showed that GIT1 can regulate cytoskeleton dynamics during cell spreading and migration. [18] [19] [20] Our previous data demonstrated that GIT1-Y392 phosphorylation is critical for phorbol 12,13-dibutyrate-induced podosome formation in A7R5 cell migration. 15 Recently, myosin 18A (a member of the myosin super family) was shown to interact with the p21-activated kinase-2/Rho guanine nucleotide exchange factor-7/GIT1 complex to modulate epithelial cell migration. 21 Our data demonstrate that GIT1 depletion in RASM impaired migration, which further confirmed previous findings, specifically in primary cultured VSMC.
Previously, we showed that GIT1 was a scaffold protein for PLCγ and mitogen-activated protein kinase-1, and was required for the sustained activation of PLCγ and ERK1/2 by AngII and EGF. 9, 10 As a surrogate for VSMC growth signaling, we measured the effect of GIT1 on both PLCγ and ERK1/2 activation in vivo. Consistent with these observations, we found that GIT1 was required for ERK1/2 activation during vascular remodeling, whereas PLCγ activation was not detected because of the limitation of functional antibody. However, using specific PLCγ and ERK1/2 inhibitor, we confirmed the critical role of PLCγ and ERK1/2 in both VSMC proliferation and migration. Moreover, we observed a stronger inhibitory effect of U73122 on VSMC proliferation, which implies additional downstream target of PLCγ other than ERK1/2.
VSMC apoptosis is another critical process during vascular remodeling. 22 Several studies show that there are 2 waves of VSMC apoptosis. 23, 24 The first wave occurs in the media within hours of injury, which leads to decreased VSMC in the vessel wall. The second wave of apoptosis occurs at later time (several days or weeks) at lower frequencies, which is important for intima formation. 23, 24 Our data demonstrated that GIT1 reduced VSMC apoptosis in vivo and in vitro. Importantly, we found that GIT1 only affected the second wave of apoptosis in vivo, and this effect is through PLCγ. The exact downstream target of PLCγ in VSMC apoptosis needs to be determined in future studies. In the current study, we use both RASM and MASM for the experiments. There are 3 reasons for this. (1) RASM are a well-established tool for VSMC functional study. (2) GIT1 KO cells are susceptible for undergoing apoptosis and grow very slowly. Therefore, it is difficult to perform cell migration assay (wound scratch experiment). (3) MASM easily transform to polyploid cells after passage 5, therefore we can only use cells between passages 3 to 5.
In conclusion, as a key scaffold protein in multiple growth factor-signaling pathways, GIT1 can regulate VSMC proliferation, migration, and apoptosis during vascular remodeling. These data suggest that GIT1 is a potential therapeutic target to reduce vascular remodeling.
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